RALTEGRAVIR Side Effects

6700060-9 | Myositis
on Apr 27, 2010 Female patient from UNITED STATES , weighting 142.0 lb, was treated with Raltegravir (View Usage). Patient experienced the following unwanted or unexpected effects: myositis (What is myositis?). Raltegravir dosage: .

6646590-X | Pain, Pancreatitis, Rash Erythematous, Rash Papular, Rash Pruritic
Patient was taking Raltegravir (View Usage). Patient had the following side effects: pain (What is pain?), pancreatitis, rash erythematous, rash papular, rash pruritic on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Raltegravir dosage: 400 Mg Bid Po. During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

6517316-5 | Convulsion
Adverse event was reported on Dec 11, 2009 by a Male patient taking Raltegravir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), diarrhoea and. Location: GERMANY , weighting 167.1 lb, After Raltegravir was administered, patient had the following side effects: convulsion. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ).

6436706-2 | Convulsion
on Nov 04, 2009 Male patient from GERMANY , weighting 167.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Raltegravir (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Raltegravir dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).


6297788-4 | Gait Disturbance, Muscular Weakness
on Aug 04, 2009 Female patient from UNITED STATES , weighting 158.5 lb, was treated with Raltegravir (View Usage). Patient had the following side effects: gait disturbance, muscular weakness. Raltegravir dosage: 400 Mg, Bid, Po. During the same period patient was treated with ENFUVIRITIDE (100 Mg, 2 Bid, Po) (View Enfuviritide Review and Enfuviritide Label ). Patient was hospitalized.

6263279-X | Dermatitis Bullous
Patient was taking Raltegravir (View Usage). After Raltegravir was administered, patient had the following side effects: dermatitis bullous on Jul 08, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 258.4 lb, was diagnosed with hiv infection (What is hiv infection?) and. Raltegravir dosage: 400mg Bid Po. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), SINGULAIR (View Singulair Review and Singulair Label ), FIBERCON (View Fibercon Review and Fibercon Label ), DOCUSATE (View Docusate Review and Docusate Label ), PERCOCET (View Percocet Review and Percocet Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), NAPROXEN (View Naproxen Review and Naproxen Label ).

6106741-2 | Abdominal Distension, Aids Related Complex, Anal Abscess, Cholestatic Liver Injury, Disease Progression, Hepatic Necrosis, Hepatitis C
Adverse event was reported on Feb 17, 2009 by a Male patient taking Raltegravir (View Usage) (Dosage: 400 Mg/bid Po) was diagnosed with hiv infection (What is hiv infection?), castleman's disease and. Location: AUSTRALIA , 45 years of age, Patient experienced the following unwanted or unexpected effects: abdominal distension, aids related complex, anal abscess, cholestatic liver injury, disease progression, hepatic necrosis, hepatitis c (What is hepatitis c?). During the same period patient was treated with TMC 125 (ETRAVIRINE) (200 Mg/bid Po) (View Tmc-125 (etravirine) Review and Tmc-125 (etravirine) Label ), DEXAMETHASONE (2 Mg/daily Po) (View Dexamethasone Review and Dexamethasone Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), CALTRATE (View Caltrate Review and Caltrate Label ), OSTELIN (ERGOCALCIFEROL) (View Ostelin (ergocalciferol) Review and Ostelin (ergocalciferol) Label ), TMC114 (View Tmc114 Review and Tmc114 Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ). Patient was hospitalized.

5789292-4 | Muscular Weakness, Pain In Extremity
on Jun 25, 2008 Female patient from UNITED STATES , weighting 159.7 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Raltegravir (View Usage). Patient had the following side effects: muscular weakness, pain in extremity. Raltegravir dosage: 400mg Bid Po. During the same period patient was treated with GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

5717317-0 | Blood Creatine Phosphokinase Increased, Blood Creatinine Increased
on Apr 24, 2008 Male patient from UNITED STATES , 50 years of age, weighting 237.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Raltegravir (View Usage). After Raltegravir was administered, patient had the following side effects: blood creatine phosphokinase increased, blood creatinine increased. Raltegravir dosage: 400mg Bid Po.

5636880-1 | Abdominal Distension, Cholestasis, Hepatic Necrosis, Hepatosplenomegaly, Hyperglycaemia, Immune Reconstitution Syndrome
Patient was taking Raltegravir (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, cholestasis, hepatic necrosis, hepatosplenomegaly, hyperglycaemia, immune reconstitution syndrome on Feb 13, 2008 from AUSTRALIA Additional patient health information: Male patient , 45 years of age, was diagnosed with hiv infection (What is hiv infection?), castleman's disease and. Raltegravir dosage: 400 Mg/bid; Po. During the same period patient was treated with ETRAVIRINE (200mg/bid;po) (View Etravirine Review and Etravirine Label ), DEXAMETHASONE TAB (2mg, Daily;po) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ). Patient was hospitalized.

5615236-1 | Agitation, Depression
Adverse event was reported on Feb 05, 2008 by a Male patient taking Raltegravir (View Usage) (Dosage: One Tablet Bid Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 64 years of age, weighting 150.0 lb, Patient had the following side effects: agitation, depression (What is depression?).

5509901-4 | Abdominal Distension, Alanine Aminotransferase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Hepatosplenomegaly, Hyperglycaemia, Immune Reconstitution Syndrome, Incorrect Dose Administered
on Oct 23, 2007 Male patient from AUSTRALIA , 45 years of age, was diagnosed with hiv infection (What is hiv infection?), castleman's disease and was treated with Raltegravir (View Usage). After Raltegravir was administered, patient had the following side effects: abdominal distension, alanine aminotransferase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatosplenomegaly, hyperglycaemia, immune reconstitution syndrome, incorrect dose administered. Raltegravir dosage: 400 Mg/bid/po. During the same period patient was treated with ETRAVIRINE (200 Mg/bid/po) (View Etravirine Review and Etravirine Label ), DEXAMETHASONE 1.5MG TAB (2 Mg/daily/po) (View Dexamethasone 1.5mg Tab Review and Dexamethasone 1.5mg Tab Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ). Patient was hospitalized.